Paediatric Home Parenteral Nutrition in the Czech Republic and Its Development: Multicentre Retrospective Study

Jitka Stýblová1, Jana Kalousová, Miroslava Adamcová

  • 1Department of Paediatric Surgery, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, In Memoriam, Prague, Czech Republic.

Insights

Paediatric home parenteral nutrition (HPN) in the Czech Republic showed comparable outcomes to developed programs, with lower mortality in gastrointestinal cases. Most patients are now treated in specialized centers, improving care quality.

Area of Science:

  • Pediatric Gastroenterology
  • Clinical Nutrition
  • Healthcare Development

Background:

  • The development of a pediatric home parenteral nutrition (HPN) program in the Czech Republic.
  • Assessing treatment quality and patient outcomes during the program's formative years.

Purpose of the Study:

  • To evaluate the effectiveness and outcomes of a developing pediatric HPN program.
  • To compare results with established international HPN programs.
  • To analyze the impact of disease type and treatment centers on patient outcomes.

Main Methods:

  • Retrospective analysis of 66 pediatric patients receiving HPN between May 1995 and June 2011.
  • Data collected from 8 treatment centers.
  • Evaluation of patient demographics, disease types, catheter usage, weaning from HPN, survival rates, and catheter-related blood stream infections (CRBSI).

Main Results:

  • 48 patients started long-term PN in their first year of life; 35 in the first month.
  • 32% of patients were weaned from HPN, 33% continued HPN long-term, and 20% died while on PN.
  • Mortality was significantly lower in patients with gastrointestinal disease (60 patients) compared to non-gastrointestinal disease (6 patients).
  • CRBSI incidence was 1.58 per 1,000 catheter days in 2009-2010.

Conclusions:

  • Pediatric HPN care in the Czech Republic achieved outcomes comparable to well-established international programs, even without initially specialized centers.
  • A shift towards specialized centers has improved the standard of care for HPN patients.
  • The findings support the feasibility of developing robust HPN programs in diverse healthcare settings.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
377
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
332